<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<td valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> <content stylecode="bold">Renal</content>
</td>
</tr>
<tr>
<td valign="top"> Subject Groups: Metformin </td>
<td align="center" valign="top"> <content stylecode="bold">C</content>
<content stylecode="bold">
<sub>max</sub>
</content>
<content stylecode="bold">
<sup>b</sup>
</content>
</td>
<td align="center" valign="top"> <content stylecode="bold">T</content>
<content stylecode="bold">
<sub>max</sub>
</content>
<content stylecode="bold">
<sup>c</sup>
</content>
</td>
<td align="center" valign="top"> <content stylecode="bold">Clearance</content>
</td>
</tr>
<tr>
<td valign="top"> Dose<sup>a</sup> (number of subjects)</td>
<td align="center" valign="top"> <content stylecode="bold">(μg/mL)</content>
</td>
<td align="center" valign="top"> <content stylecode="bold">(hrs)</content>
</td>
<td align="center" valign="top"> <content stylecode="bold">(mL/min)</content>
</td>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="4" valign="top"> <sup>a</sup>All doses given fasting except the first 18 doses of the multiple-dose studies</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>b</sup>Peak plasma concentration</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>c</sup>Time to peak plasma concentration</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>d</sup>SD = single dose</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>e</sup>Combined results (average means) of five studies: mean age 32 years (range 23-59 years)</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>f</sup>Kinetic study done following dose 19, given fasting</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>g</sup>Elderly subjects, mean age 71 years (range 65-81 years)</td>
</tr>
<tr>
<td colspan="4" valign="top"> <sup>h</sup>CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td valign="top"> Healthy, nondiabetic Adults:</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr>
<td valign="top"> 500 mg SD<sup>d </sup>(24)</td>
<td align="center" valign="top"> 1.03 (±0.33)</td>
<td align="center" valign="top"> 2.75 (±0.81)</td>
<td align="center" valign="top"> 600 (±132)</td>
</tr>
<tr>
<td valign="top"> 850 mg SD (74)<sup>e</sup>
</td>
<td align="center" valign="top"> 1.60 (±0.38)</td>
<td align="center" valign="top"> 2.64(±0.82)</td>
<td align="center" valign="top"> 552 (±139)</td>
</tr>
<tr>
<td valign="top"> 850 mg t.i.d. for 19 doses<sup>f</sup> (9)</td>
<td align="center" valign="top"> 2.01 (±0.42)</td>
<td align="center" valign="top"> 1.79(±0.94)</td>
<td align="center" valign="top"> 642 (±173)</td>
</tr>
<tr>
<td valign="top"> Adults with type 2 diabetes: </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr>
<td valign="top"> 850 mg SD (23)</td>
<td align="center" valign="top"> 1.48 (±0.5)</td>
<td align="center" valign="top"> 3.32 (±1.08)</td>
<td align="center" valign="top"> 491 (±138)</td>
</tr>
<tr>
<td valign="top"> 850 mg t.i.d. for 19 doses<sup>f</sup> (9)</td>
<td align="center" valign="top"> 1.90 (±0.62)</td>
<td align="center" valign="top"> 2.01 (±1.22)</td>
<td align="center" valign="top"> 550 (±160)</td>
</tr>
<tr>
<td valign="top"> Elderly<sup>g</sup>, healthy nondiabetic adults: </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr>
<td valign="top"> 850 mg SD (12)</td>
<td align="center" valign="top"> 2.45 (±0.70)</td>
<td align="center" valign="top"> 2.71 (±1.05)</td>
<td align="center" valign="top"> 412 (±98)</td>
</tr>
<tr>
<td valign="top"> Renal-impaired adults:</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr>
<td valign="top"> 850 mg SD</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr>
<td valign="top"> Mild (CL<sub>cr</sub>
<sup>h</sup> 61-90 mL/min) (5)</td>
<td align="center" valign="top"> 1.86 (±0.52)</td>
<td align="center" valign="top"> 3.20 (±0.45)</td>
<td align="center" valign="top"> 384 (±122)</td>
</tr>
<tr>
<td valign="top"> Moderate (CL<sub>cr</sub> 31-60 mL/min) (4)</td>
<td align="center" valign="top"> 4.12 (±1.83)</td>
<td align="center" valign="top"> 3.75 (±0.50)</td>
<td align="center" valign="top"> 108 (±57)</td>
</tr>
<tr>
<td valign="top"> Severe (CL<sub>cr</sub> 10-30 mL/min) (6)</td>
<td align="center" valign="top"> 3.93 (±0.92)</td>
<td align="center" valign="top"> 4.01 (±1.10)</td>
<td align="center" valign="top"> 130 (±90)</td>
</tr>
</tbody>
</table>